1.Patterns of daily ambulatory activity and the onset of metabolic syndrome in middle-aged and older Japanese women: the Toon Health Study.
Naofumi YAMAMOTO ; Koutatsu MARUYAMA ; Isao SAITO ; Kiyohide TOMOOKA ; Takeshi TANIGAWA ; Ryoichi KAWAMURA ; Yasunori TAKATA ; Haruhiko OSAWA
Environmental Health and Preventive Medicine 2025;30():11-11
BACKGROUND:
This cohort study aimed to identify the accumulation patterns of objectively measured ambulatory activity (AA) variables in the middle-aged and older Japanese women and examine the relationship of these derivative patterns with onset of metabolic syndrome (MetS).
METHODS:
A total of 794 women (mean age: 56.2 years) provided objectively assessed AA data using a uniaxial accelerometer. The number of steps, time accumulated in light-intensity AA (LIAA) and moderate-to-vigorous intensity AA (MVAA) and the ratio of MVAA to total AA (LIAA + MVAA) were calculated. Latent profile analysis was used to identify participant groups based on their distinct AA patterns. Logistic regression models were used to assess the association of groups with the onset of MetS after adjusting for age, sex, education, alcohol habit, smoking habit, energy intake, and the number of MetS components present at baseline.
RESULTS:
Four distinct groups were identified: Group A had low levels of the AA variable; group B accumulated a certain number or more steps primarily through MVAA; group C accumulated a certain number or more steps primarily through LIAA; and group D had high level of the AA variables. Over the course of the 5-year follow-up period, 61 participants (7.7%) developed MetS. The multivariate-adjusted odds ratio (95% confidence interval) for onset of MetS in groups B, C, and D relative to group A were 0.416 (0.166-1.218), 0.451 (0.223-0.914), and 0.933 (0.365-2.382), respectively. Group C had a significantly lower odds ratio of MetS onset than group A.
CONCLUSION
AA patterns accumulating a certain number or more steps, regardless of the intensity of AA, may help reduce the risk of MetS compared to inactive AA patterns.
Humans
;
Metabolic Syndrome/etiology*
;
Female
;
Middle Aged
;
Japan/epidemiology*
;
Aged
;
Exercise
;
Cohort Studies
;
Accelerometry
;
Risk Factors
;
East Asian People
2.Effects of speech duration and voice volume on the respiratory aerosol particle concentration.
Tomoki TAKANO ; Yiming XIANG ; Masayuki OGATA ; Yoshihide YAMAMOTO ; Satoshi HORI ; Shin-Ichi TANABE
Environmental Health and Preventive Medicine 2025;30():14-14
BACKGROUND:
SARS-CoV-2 (COVID-19) is transmitted via infectious respiratory particles. Infectious respiratory particles are released when an infected person breathes, coughs, or speaks. Several studies have measured respiratory particle concentrations through focusing on activities such as breathing, coughing, and short speech. However, few studies have investigated the effect of speech duration.
METHODS:
This study aimed to clarify the effects of speech duration and volume on the respiratory particle concentration. Study participants were requested to speak at three voice volumes across five speech durations, generating 15 speech patterns. Participants spoke inside a clean booth where particle concentrations and voice volumes were measured and analyzed during speech.
RESULTS:
Our findings suggest that as speech duration increased, the aerosol number concentration also increased. Through focusing on individual differences, we considered there might be super-emitters who emit more aerosol particles than the average human. Two participants were identified as statistical outliers (aerosol number concentration, n = 1; mass concentration, n = 1).
CONCLUSIONS
Considering speech duration may improve our understanding of respiratory particle concentration dynamics. Two participants were identified as potential super-emitters.
Humans
;
Male
;
Speech/physiology*
;
Adult
;
Female
;
COVID-19/transmission*
;
Respiratory Aerosols and Droplets
;
Voice
;
SARS-CoV-2
;
Time Factors
;
Young Adult
;
Aerosols/analysis*
3.Identification of miRNAs induced by low-dose methylmercury exposure and their roles in inflammatory responses using human aortic endothelial cells.
Rika MATSUYAMA ; Athira NANDAKUMAR ; Munekazu YAMAKUCHI ; Saekhol BAKRI ; Shiroh TANOUE ; Mayumi TSUJI ; Megumi YAMAMOTO ; Teruto HASHIGUCHI ; Chihaya KORIYAMA
Environmental Health and Preventive Medicine 2025;30():93-93
BACKGROUND:
Exposure to methylmercury (MeHg) is predominantly attributed to consumption of marine products. However, the general population is exposed to low MeHg levels, which can induce chronic inflammation. Although some MeHg-related microRNAs (miRNAs) have been reported, their functions remain elusive. The objective of this study was to identify the miRNAs induced by low-level MeHg exposure in a human endothelial cell line (HAECs). This study aimed to determine the specific miRNAs induced by low-level MeHg exposure using a HAECs as a potential novel and sensitive biomarker. The roles of miRNAs in inflammatory processes have been examined.
METHODS:
Using HAECs, a miRNA microarray assay was performed to identify miRNAs with altered expression upon exposure to a non-cytotoxic MeHg level (0.1 and 1.5 µM). The expression patterns of interleukin-6 and -8, cyclooxygenase 2 (COX-2), RelB, and prostaglandin E2 (PGE2) were examined after transfection of the identified miRNAs with mimics/inhibitors.
RESULTS:
Although the microarray assay identified six MeHg-specific miRNAs, miR-3613-5p, upregulated by 0.1 and 1.5 µM MeHg exposures, demonstrated the best reproducibility in HAECs. Transfection with the miR-3613-5p mimic enhanced the MeHg-induced inflammatory responses, including PGE2 and COX-2 protein levels, whereas the miR-3613-5p inhibitor suppressed these inflammatory responses.
CONCLUSION
This study observed that miR-3613-5p is induced by low-dose MeHg exposure, plays a crucial role in the inflammatory process, and could serve as a novel and sensitive biomarker for low-level MeHg exposure.
Methylmercury Compounds/adverse effects*
;
Humans
;
MicroRNAs/genetics*
;
Endothelial Cells/metabolism*
;
Inflammation/genetics*
;
Cell Line
;
Aorta/drug effects*
;
Biomarkers/metabolism*
4.Tracking a patient with no technetium-99m-pyrophosphate myocardial uptake at surgical valve replacement for aortic stenosis.
Koji TAKAHASHI ; Daisuke SASAKI ; Takaaki IWAMURA ; Shuhei YAMAMOTO ; Mitsuharu UEDA ; Nobuhisa YAMAMURA ; Mako YOSHINO ; Daijiro ENOMOTO ; Hiroe MORIOKA ; Shigeki UEMURA ; Takafumi OKURA ; Tomoki SAKAUE ; Katsuji INOUE
Journal of Geriatric Cardiology 2025;22(9):828-833
5.2023 Philippine clinical practice guidelines on the diagnosis and management of chronic heart failure with reduced ejection fraction for primary care physicians.
Maria Teresa B. ABOLA ; Felix Eduardo R. PUNZALAN ; Jose Donato A. MAGNO ; Raymond V. OLIVA ; Erlyn P. CABANAG-DEMERRE ; Milagros L. ESTRADA-YAMAMOTO ; Eden A. GABRIEL ; Antonio S. SIBULO JR. ; Maria Encarnita B. LIMPIN ; Gilbert C. VILELA
Philippine Journal of Cardiology 2025;53(2):12-34
INTRODUCTION
Heart failure (HF) is a common cause of hospitalization, heart failure-related readmission, poor quality of life, and mortality. It also poses a substantial economic burden. The heart failure clinical practice guideline (HFCPG) was developed to provide evidence-based recommendations on the diagnosis and management of chronic HF with reduced ejection fraction (HFrEF) among adult Filipino patients in the outpatient setting for primary care physicians.
METHODSThe GRADE approach and an Evidence-to-Decision framework were used to evaluate the evidence and formulate recommendations. The strength and direction of each recommendation were determined through voting, with consensus reached if 75% of all CP members agreed.
RESULTSThe HFCPG provides 19 recommendations and one good practice statement in response to 14 identified clinical questions. Careful history-taking and physical examination, use of chest x-ray to detect cardiomegaly and/or pulmonary congestion, two-dimensional echocardiography for HF diagnosis, and baseline determination of serum sodium, potassium, and creatinine to guide management have been highly recommended; however, the 12-lead electrocardiogram should not be solely used for HF diagnosis. Judicious use of diuretics to relieve congestion, use of selected beta-blockers, renin-angiotensin-aldosterone blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors are strongly recommended for the treatment of HFrEF.
CONCLUSIONHFrEF is a complex condition that requires early recognition and careful management. Guideline-directed medical therapies, particularly the evidence-based pillars of treatment, are recommended, as well as early discussion of palliative care, timely determination of advanced heart failure and the need for referral to higher levels of care.
Human ; Heart Failure ; Outpatient Care ; Ambulatory Care ; Primary Health Care
7.Strategies for Providing High-quality Palliative Care in Settings without Palliative Care Specialists: A Scoping Review
Ayumi TAKAO ; Saori TAMURA ; Miwa AOKI ; Sena YAMAMOTO ; Yoshiyuki KIZAWA ; Harue ARAO
Palliative Care Research 2025;20(1):9-21
Objective: To identify effective strategies to provide high-quality palliative care in settings where palliative care specialists are scarce, particularly in Japan. Methods: A scoping review of literature (in English) was conducted using Arksey and O’Malley’s methodological framework. Electronic databases (MEDLINE, CINAHL, and the Cochrane Library) were searched and supplemented with a manual search of relevant journal articles. Results: Nine studies met our inclusion criteria. Four key strategies have emerged: (1) developing a video consultation system to improve the timeliness of care; (2) providing online consultations by specialists to support general practitioners; (3) training nurses to manage the palliative care process; and (4) transferring knowledge and information from experts to non-specialists. Conclusion: Based on these strategies, creating a system tailored to the specific needs and readiness of palliative care in Japan is necessary. The effectiveness of these strategies should be evaluated in future research.
8.The Impact of Lifestyle Habits before, during, and after Primary Eradication of Helicobacter pylori: A Descriptive Study
Takashi HIROSE ; Ryohei YAMAMOTO ; Sumire SUZUKI ; Fumi MATSUKI ; Miyuki MORITA ; Hiroki INUZUKA ; Tatsuhiko SUZUKI ; Takahito YOSHIDA ; Yoshihiro ONISHI
An Official Journal of the Japan Primary Care Association 2025;48(1):2-10
Introduction: We aimed to evaluate the impact of lifestyle modifications on the risk of eradication failure in patients undergoing first-line therapy for Helicobacter pylori infection.Methods: A survey was conducted in a community pharmacy to assess changes in alcohol consumption, smoking, and high-fat diet intake before, during, and after first-line therapy for H. pylori infection in enrolled patients.Results: A total of 100 patients (response rate: 3.4%) were included in the analysis. Before therapy, 20 patients (20%) smoked, 35 patients (35%) consumed alcohol, and 91 patients (91%) had a high-fat diet. During therapy, the proportion of patients who changed their habits was 15.0% (3/20) for smoking, 71.4% (25/35) for alcohol consumption, and 28.6% (26/91) for high-fat diet. However, the continuation of these changes post-therapy was minimal.Conclusion: Among patients undergoing first-line therapy for H. pylori infection, lifestyle habits that increase the risk of eradication failure were prevalent, with many patients maintaining their habits during therapy except for alcohol consumption. These findings provide fundamental data for lifestyle counselling during eradication therapy.
10.Study on Effective Designs for the Identification and Differentiation of Tablets Using KH Coder
Yuka SHONO ; Fumika NAKAGAWA ; Hitomi YAMAMOTO ; Saki GOBARA ; Yuna TOMATSU ; Hiromu MIYAZAKI ; Kenichi OGAWA ; Hidenori SAGARA
Japanese Journal of Drug Informatics 2025;26(4):186-197
Background: This study surveyed pharmacists registered with the Yamaguchi Prefectural Pharmacists Association to determine the key elements of tablet printing design that enhance visibility and distinguishability during dispensing.Objectives: The purpose of this study is to identify suitable design components for tablets that enhance visibility and distinguishability by utilizing text data.Methods: Given the high risk of medication errors due to similar-looking tablets, the study employed KH Coder for text mining analysis of free-text responses.Results: Results indicated that design elements such as "horizontal writing," "straight lines, " and "emphasis on characters" significantly improve visibility and distinguishability, particularly for similar-looking tablets. The findings from this study provide specific guidelines for optimal tablet design, aiming to improve pharmacists' efficiency and enhance medication safety.Conclusions: KH Coder proved to be a valuable tool for analyzing qualitative data in the medical field. While the study focused on pharmacists in Yamaguchi Prefecture, expanding the survey to a national scale is recommended to validate and generalize the findings. This research supports the development of standardized tablet designs that can minimize dispensing errors and ensure patient safety, highlighting the importance of effective tablet printing design in pharmaceutical practice.


Result Analysis
Print
Save
E-mail